Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Change in Accured Expenses (2016 - 2025)

Mesa Laboratories' Change in Accured Expenses history spans 16 years, with the latest figure at $5.1 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 32.48% year-over-year to $5.1 million; the TTM value through Dec 2025 reached $6.1 million, up 625.22%, while the annual FY2025 figure was $9.5 million, 868.93% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $5.1 million at Mesa Laboratories, up from -$2.6 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $9.6 million in Q1 2025 and bottomed at -$5.9 million in Q2 2025.
  • The 5-year median for Change in Accured Expenses is $757500.0 (2021), against an average of $195600.0.
  • The largest annual shift saw Change in Accured Expenses tumbled 1158.76% in 2021 before it skyrocketed 959.17% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $3.2 million in 2021, then tumbled by 79.71% to $648000.0 in 2022, then surged by 149.85% to $1.6 million in 2023, then skyrocketed by 135.64% to $3.8 million in 2024, then surged by 32.48% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Change in Accured Expenses are $5.1 million (Q4 2025), -$2.6 million (Q3 2025), and -$5.9 million (Q2 2025).